• IPR MDR report
  • CHI whitepapers
  • ProServices
  • Clinical Informatics News
  • MDX Report

Drug Diagnostic Co-Development:
Biomarkers in Personalized Medicine


Drug Diagnostic Co-Development

Life Science Podcast

The New Paradigm of Data Intensive/Data Rich Protein Informatics
Eugene Kolker, Ph.D., Chief Data Officer, Center for Developmental Therapeutics, Children’s Hospital Seattle
Interview with Mary Ann Brown Click here to download


Life Science Media Library

Educational DVDs are one of many assets available from the Cambridge Healthtech Institute Life Science Media Library.

View and order all our DVDs and CDs at healthtech.com/cddvd


CHI News Releases


09.25.14 Final Agenda posted for Molecular Med Tri-Con February 15-20, 2015


09.25.14 Call for papers posted for Clinical Research Informatics World May 6-7, 2015


09.09.14  Call for papers posted for PEGS: the essential protein engineering summit May 4-8, 2015


08.19.14  Call for papers posted for Molecular Diagnostics Europe April 14-16, 2015


08.18.14  Call for papers posted for PEGS Summit China March 31-April 2, 2015


More Conference Updates...

Careers
Available Positions:
Why work for CHI?
SENIOR SYSTEMS ANALYST


Linkedin Twitter Xing Youtube

 


Conferences & Courses
Antibodies Against Membrane Protein Targets - Part 1
October 8-9, 2014 | Boston, MA
As the pharmaceutical and biotech industries shift their attentions from small molecule therapeutics to biologics, an increased amount of attention is being paid to the prospect of membrane proteins as drug targets for antibodies and other protein scaffol

Life Science Media Library
Introduction to Adoptive T Cell Therapies DVD
May 5, 2014 |
This digital course will aim to guide the researcher in designing studies for accelerated stability testing of biologics. The course will begin with basic underlying concepts governing protein drug product stability, and focus on design principles for meaning stress and accelerated stability testing of not only the protein of interest but also of excipients and primary packaging components. Strategies to handle complexities arising from their interactions will also be discussed.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Digital PCR Technologies and Tools for Precision Diagnostics
October 6-8, 2014 | La Jolla, CA
Digital PCR Conference: Technologies and Tools for Precision Diagnostics Digital PCR, at its core, is simply a single molecule counting method that quantitatively measures absolute DNA and eliminates the need for standard curves.

Life Science Media Library
Laboratory Developed Tests
May 7, 2013 |
Laboratory-developed tests, which are developed, validated and performed by clinical laboratories, have come under increased scrutiny by the FDA. Cambridge Healthtech Institute's Laboratory-Developed Tests DVD will cover the latest developments from the FDA and the positions and recommendations put forward by medical and industry professional societies; the challenges of meeting CLIA regulations in the new age of genomics; and the complexities of implementing NGS assays into clinical laboratories.

Conferences & Courses
Maximizing Efficiency in Discovery
October 9-10, 2014 | Boston, MA
Maximizing Efficiency in Discovery Conference, part of Discovery on Target 2014 in Boston, includes strategies for validating novel drug targets, and developing tool compounds and inhibitors.

Life Science Media Library
Impact of Affordable Care Act and the Sunshine Act on Industry
February 4, 2013 |
In this DVD, we will discuss the new "sunshine provisions" in the Patient Protection and Affordable Health Care Act ("PPACA") and its implications and effects on clinical trial operations. Key topics to be addressed: Insurance coverage and strategies to improve clinical trial enrollment What is the Sunshine Act and what are the company’s legal requirements? Opportunities in the Biosimilars FDA rules and changes in operations What are first steps and strategies to become compliant with state and federal laws? How can companies maintain flexibility in dealing with evolving legislation? What business processes and systems are involved? Implementation struggles: Centralization of all payments; FMV process and standardization and the effect Change Management with Study teams: The balance of compliance and challenges of patient recruitment, site shortage
Reports
Cancer Immunotherapy Report
Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies, published by Insight Pharma reports and written by Allan B. Haberman focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians and patients, but only recently (2010s era) has it actually been within reasonable reach. Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies covers three principle therapies that have been in the works for cancer patients.

Conferences & Courses
Antibodies Against Membrane Protein Targets - Part 2
October 9-10, 2014 | Boston, MA
As the pharmaceutical and biotech industries shift their attentions from small molecule therapeutics to biologics, an increased amount of attention is being paid to the prospect of membrane proteins as drug targets for antibodies and other protein scaffol

Life Science Media Library
Operational Excellence in Bioprocessing DVD
August 18, 2014 |
The physical properties of drugs influence all aspects of their discovery, development, formulation, and administration. They are key to efficacy, effective assays, and in vivo delivery. This course will discuss latest trends and state-of-the art of prediction and measurement of key properties. Properties important for enhanced efficacy, delivery, and formulation pKa, tautomerism, crystallization, others Computational prediction: What works - what doesn’t Experimental best practices
Reports
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
Discovery on Target
October 8-10, 2014 | Boston, MA
Cambridge Healthtech Institute will host its 12th Annual Discovery on Target event showcasing current and emerging “hot” targets for the pharmaceutical industry, October 8 – 10, 2014 in Boston, MA.

Life Science Media Library
Trends in Physical Properties of Drugs
April 22, 2014 |
The physical properties of drugs influence all aspects of their discovery, development, formulation, and administration. They are key to efficacy, effective assays, and in vivo delivery. This course will discuss latest trends and state-of-the art of prediction and measurement of key properties. Properties important for enhanced efficacy, delivery, and formulation pKa, tautomerism, crystallization, others Computational prediction: What works - what doesn’t Experimental best practices
Reports
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
Re-Entering Antibacterial Drug Development Summit
October 27-29, 2014 | Boston, MA
Several factors including diminishing financial return, lack of new discovery platforms and others, had a cooling effect on pharmaceutical companies’ activity in the area of antibacterial drug development.

Life Science Media Library
Clinical Trial Monitoring and Compliance
February 4, 2013 |
In this DVD, we will discuss the ever-changing role of the CRA and explore ways in which this relationship can be leveraged to maximize productivity with study sites. Key topics to be addressed: How to build and maintain the relationship between sponsor and site Ways to partner with your sites during different phases of clinical trials How to have an enrollment discussion with your site; define mutual goals and expectations How to ensure ROI on territory development activities
Reports
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
Maximizing Efficiency in Discovery
October 9-10, 2014 | Boston, MA
Maximizing Efficiency in Discovery Conference, part of Discovery on Target 2014 in Boston, includes strategies for validating novel drug targets, and developing tool compounds and inhibitors.

Life Science Media Library
Strategies for Protein Purification and Overcoming Aggregation
January 20, 2013 |
Together with input from Sarah Bondos from Texas A&M University, Mario Lebendiker of the Wolfson Centre for Applied Structural Biology at The Hebrew University of Jerusalem provides an indepth overview of protein purification with a particular focus on aggregation problems. This course reviews: common causes of protein aggregation during expression and purification, methods to detect the presence of aggregates, the types and properties of chemicals that, when added to buffers, may improve protein solubility, and methods to screen these additives to rapidly optimize the solubility of your protein.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Targeting Ocular Disorders
October 6-7, 2014 | Boston, MA
Targeting Ocular Disorders will address targeting of ophthalmic medications and treatments and will provide the latest results in the field, along with novel and emerging targets that hold promise in treating these crippling conditions.

Life Science Media Library
Trends in Physical Properties of Drugs
April 22, 2014 |
The physical properties of drugs influence all aspects of their discovery, development, formulation, and administration. They are key to efficacy, effective assays, and in vivo delivery. This course will discuss latest trends and state-of-the art of prediction and measurement of key properties. Properties important for enhanced efficacy, delivery, and formulation pKa, tautomerism, crystallization, others Computational prediction: What works - what doesn’t Experimental best practices

Conferences & Courses
Targeting Ocular Disorders
October 6-7, 2014 | Boston, MA
Targeting Ocular Disorders will address targeting of ophthalmic medications and treatments and will provide the latest results in the field, along with novel and emerging targets that hold promise in treating these crippling conditions.

Life Science Media Library
Introduction to Adoptive T Cell Therapies DVD
May 5, 2014 |
This digital course will aim to guide the researcher in designing studies for accelerated stability testing of biologics. The course will begin with basic underlying concepts governing protein drug product stability, and focus on design principles for meaning stress and accelerated stability testing of not only the protein of interest but also of excipients and primary packaging components. Strategies to handle complexities arising from their interactions will also be discussed.

Conferences & Courses
Digital PCR Technologies and Tools for Precision Diagnostics
October 6-8, 2014 | La Jolla, CA
Digital PCR Conference: Technologies and Tools for Precision Diagnostics Digital PCR, at its core, is simply a single molecule counting method that quantitatively measures absolute DNA and eliminates the need for standard curves.

Life Science Media Library
Next Generation Sequencing
August 14, 2012 |
If you are confused by the evolving, rapidly changing, and dynamic nature of the Next Generation Sequencing market, then this is the course for you. This course will provide you with a comprehensive, clear outline of the various sequencing technologies currently available, their best suited applications, and which analysis strategies go with what applications in order to get the best answer from the data.

Conferences & Courses
Advances in Prenatal Molecular Diagnostics
November 5-7, 2014 | Boston, MA
prenatal molecular diagnostics conference The field of prenatal diagnosis is undergoing rapid and significant change, as a variety of molecular diagnostics are transforming the type and quality of data that can be provided to pregnant women and their phy

Life Science Media Library
Clinical Genome Sequencing
June 11, 2012 |
The move to push genome sequencing into routine clinical practice requires arguably as much skill in navigating bureaucracy as mapping and interpreting base pairs. This short course provides practical information on crafting clinical sequencing and analysis pipeline strategies while navigating the route of CAP and CLIA certification by those who have sailed through these uncharted waters.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Big Data Analytics and Solutions
October 8-9, 2014 | Boston, MA
Big Data Analytics and Solutions Conference, part of Discovery on Target 2014 in Boston, covers big data approaches to map diseases, identify biomarkers and discover targets for potential therapies.

Life Science Media Library
IT Project Planning and Implementation
April 9, 2013 |
Key topics to be addressed: This session is designed to help the project team to understand and create a project plan for the delivery of the project to the portfolio; To provide assistance to project teams in the delivery of the Significant and high visible projects to portfolio where success is critical to both the team and the organization The success of any project depends on the planning activities especially delivery
Reports
Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
Digital PCR Technologies and Tools for Precision Diagnostics
October 6-8, 2014 | La Jolla, CA
Digital PCR Conference: Technologies and Tools for Precision Diagnostics Digital PCR, at its core, is simply a single molecule counting method that quantitatively measures absolute DNA and eliminates the need for standard curves.

Life Science Media Library
qPCR in Molecular Diagnostics
February 12, 2013 |
Quantitative real-time PCR is a valuable technology used for diagnostics of diseases such as cancer and infectious diseases, and for the detection of bacterial, fungal and viral pathogens. This course covers aspects of incorporating qPCR into standard molecular diagnosis including the challenges involved, an overview of the technology available, and next steps.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Targeting Ocular Disorders
October 6-7, 2014 | Boston, MA
Targeting Ocular Disorders will address targeting of ophthalmic medications and treatments and will provide the latest results in the field, along with novel and emerging targets that hold promise in treating these crippling conditions.

Life Science Media Library
Understanding EMT: Mechanisms and Metastasis to MET
February 20, 2012 |
Epethelial Mesenchymal Transition (EMT) plays a critical role in cancer cells, but understanding of its mechanisms is incomplete. EMT causes cells to develop increased motility, invasiveness, and greater resistance to apoptosis. These changes make the cells more like stem cells, allowing them to self renew. This course provides a framework of the underlying molecular mechanisms while addressing stem cells, and cancer progression, cMET and their activity as anti-metastasis agents, and the Mesenchymal-Epethelial Transition (MET) as an essential process for tumor re-initiation, colonization, and metastasis.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

ABOUT CHI


CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and Clinical Informatics News.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related in commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.


CONFERENCES 


REPORTS 


BARNETT EDUCATIONAL SERVICES 


CONSULTING 


PUBLICATIONS & eNEWSLETTERS 


PROFESSIONAL SERVICES 


KNOWLEDGE FOUNDATION 


EXECUTIVE TEAM 


CAREERS